首页> 外文期刊>World Journal of Gastroenterology >A case of scirrhous gastric cancer with peritonitis carcinomatosa controlled by TS-1~® + paclitaxel for 36 mo after diagnosis
【24h】

A case of scirrhous gastric cancer with peritonitis carcinomatosa controlled by TS-1~® + paclitaxel for 36 mo after diagnosis

机译:诊断为TS-1〜®+紫杉醇控制的硬化性胃癌伴腹膜癌癌36个月

获取原文
获取原文并翻译 | 示例
           

摘要

A 34-year-old female complaining of abdominal fullness was diagnosed as scirrhous gastric cancer (type 4') with peritonitis carcinomatosa in July 2002. A combined chemotherapy regimen was selected to control massive ascites; TS-1~® 80 mg/m~2 was given orally on d 1-14, 22-35, and paclitaxel 50 mg/m2 was administered intravenously on d 1, 8, 22 and 29. After 2 courses of this regimen, the primary tumor was markedly reduced, and ascites completely vanished. Alopecia (grade 1, since d 30), leukocytopenia (grade 2, on d 34) and anemia (grade 2, on d 34) were the only adverse events throughout the following courses. The chemotherapy was effective for 28 mo, and then it was discontinued upon the patient's own request, and she survived for 36 mo after diagnosis.
机译:2002年7月,一名34岁的主诉腹腔充盈的女性被诊断为患有硬胃炎(4'型)并伴有腹膜癌癌。选择了一种联合化疗方案来控制大规模腹水。在第1-14、22-35天口服TS-1〜®80 mg / m〜2,在第1、8、22和29天静脉注射紫杉醇50 mg / m2。原发肿瘤明显减少,腹水完全消失。在接下来的整个疗程中,脱发症(1级,自30天起),白细胞减少症(2级,在34天)和贫血(2级,在34天)是唯一的不良事件。化疗有效期为28个月,然后应患者自己的要求中止化疗,诊断后存活了36个月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号